Home

Attività scientifica

Pubblicazioni

Di seguito vengono elencate alcune tra le più significative pubblicazioni scientifiche prodotte dal Servizio di Medicina delle Dipendenze.

  1. Mezzelani P, Quaglio GL, Venturini L, Lugoboni F. GICS: Significato del portatore dell'anti-HBc isolato. Studio in 1797 tossicodipendenti. Recenti Progressi in Medicina 1994; 85: 419-24.

  2. Mezzelani P, Manara F, Quaglio GL, Bossi C, Venturini L. Follow-up di 165 eroinodipendenti seguiti presso un ambulatorio ospedaliero negli anni 1981-85. Boll. Farmacodip. e Alcolis. 1994; XVII: 30-4.

  3. Quaglio GL, Mezzelani P, Lugoboni F, Venturini L, GICS. Attendibilità del "Tine Test" rispetto alla Mantoux come screening di massa per la TBC per i tossicodipendenti dei Ser.T. Boll. Farmacodip. e Alcolis.1995; XVIII: 61-4.

  4. Mezzelani P, Quaglio GL, Venturini L, Lugoboni F, GICS, Friedman S and Des Jarlais DC. A multicenter study on the causes of death among Italian injecting drug users. AIDS has overtaken overdose as the principal cause of death. Aids Care 1998; 10: 61-67.

  5. Nouguè S, Quaglio GL. El estomago y el intestino: unos organos con pluriempleo. Med Clin (Barc) 1998; 111: 338-340.

  6. Nouguè S, Quaglio GL. El sindrome del body-packer. Medicina Intensiva 1999; 23: 32-33.

  7. Lugoboni F, Quaglio GL, Residori M, Mecenero V, Mezzelani P. Hepatitis A virus vaccination among injecting drug users: Do We have to change the vaccination schedule? Clin Infect Dis. 2000;31:847-8.

  8. Quaglio GL, Lugoboni F, Vento S, Lechi A, Accordini A, Bossi C, Faccini M, Mecenero V, Pani A, Pantalena M, Residori M, Mezzelani P. Isolated presence of antibody to hepatitis B core antigen in injection drug users: do they need to be vaccinated? Clin Infect Dis. 2001;32:E143-4.

  9. Quaglio GL, Lugoboni F, Mezzelani P. La sindrome dei body packer e dei body stuffer. Boll. Farmacodip. e Alcolis. 2001; XXIV: 48-53.

  10. Quaglio GL, Talamini G, Lechi A, Venturini L, Lugoboni F, Mezzelani P; Gruppo Intersert di Collaborazione Scientifica (GICS). Study of 2708 heroin-related deaths in north-eastern Italy 1985-98 to establish the main causes of death. Addiction. 2001; 96:1127-37.

  11. Lugoboni F, Quaglio GL, Lechi A Mezzelani P. No positive tests for syphilis in 6 years of observation among heroin drug users in north-eastern Italy. Addiction. 2002;97:104-5.

  12. Quaglio GL, Lugoboni F, Talamini G, Lechi A Mezzelani P. Prevalence of TB infection and comparison of multiple puncture liquid tuberculin test and Mantoux test among drug users. Scand J Infect Dis. 2002; 34:574-6.

  13. Quaglio GL, Des Jarlais DC, Talamini G, Lechi A, Venturini L, Lugoboni F, GICS, Mezzelani P. Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of seroconversion. Addiction 2002; 97:985-92.

  14. Quaglio GL, Lugoboni F, Pajusco B, Sarti M, Mezzelani P. Managerial considerations in implementing hepatitis B vaccination programs among drug-using cohorts. Addiction 2002; 97: 1607-1614.

  16. Braglia D, Gerra G, Mezzelani P, Quaglio GL, Timpano M, Zaimovic A. Cocaina: farmacocinetica, abuso, dipendenza, detossificazione e trattamento. In: Nizzoli U, Pissacroia M: Trattamento completo degli abusi e delle dipendenze. Padova: Piccin, 2002: 46-58.

  17. Lugoboni F, Quaglio GL, Pajusco B, Mezzelani P. La dipendenza da fumo. Personalità/Dipendenze, 2002; 1: 41-56.

  18. Quaglio GL, F Lugoboni F, Pajusco B, Sarti M, Talamini G, GICS, Mezzelani P, Des Jarlais DC. Hepatitis C Virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy. J Viral Hepat. 2003;10:394-400.

  19. Quaglio GL, Lugoboni F, Pajusco B, Sarti M, Talamini G, Mezzelani P, Des Jarlais DC. Factors associated with hepatitis C virus infection (HCV) in injecting and non-injecting drug users in Italy. Clin Infect Dis. 2003; 37:33-40.

  20. Lugoboni F, Quaglio GL, Sarti M, Pajusco B, Mezzelani P, Lechi A. Curare il tabagismo: un obiettivo di salute primario. Ann Ital Med Int 2003; 18:73-82.

  21. Quaglio GL. Il Doping. In: La salute è: indicazioni pratiche per un miglior stile di vita. Edizioni Libreria Cortina Verona, 151-153, 2003.

  22. Lugoboni F, Quaglio G, Mezzelani P, Pajusco B, Casari R, Lechi A. Improving compliance in internal medicine: the motivational discussion. Ann Ital Med Int. 2004;19:155-62.

  23. Quaglio G, Lugoboni F, Pajusco B, Fornasiero A, Mezzelani P, Lechi A. Clinical manifestations of cocaine abuse. Ann Ital Med Int. 2004 ;19:291-301.

  24. Lugoboni F, Quaglio G, Pajusco B, Civitelli P, Romano L, Bossi C, Spilimbergo I, Mezzelani P. Immunogenicity, reactogenicity and adherence to a combined hepatitis A and B vaccine in illicit drug users. Addiction. 2004; 99:1560-4.

  25. Quaglio G, Lugoboni F, Mezzelani P. HBV vaccination should be performed in service centres for drug users: an Italian experience. J Public Health. 2004; 26:320.

  26. Quaglio G, Pajusco B, Civitelli P, Migliozzi S, Des Jarlais DC, Romano L, Lechi A, Mezzelani P, Lugoboni F. Immunogenicity, reactogenicity and adherence with hepatitis A vaccination among drug users. Drug Alcohol Depend. 2004;74:85-8.

  27. Lugoboni F, Migliozzi S, Mezzelani P, Pajusco B, Ceravolo R, Quaglio G. Progressive decrease of hepatitis B in a cohort of drug users followed over a period of 15 years: the impact of anti-HBV vaccination. Scand J Infect Dis. 2004; 36:131-3.

  28. Quaglio GL, Pajusco B, Civitelli P, Migliozzi S, Don C. Des Jarlais, Romanò L, Lechi A, Mezzelani P, Lugoboni F. Immunogenicity, reactogenicity and adherence with hepatitis A vaccination among drug users. Drug Alcohol Depend. 2004;74:85-8.

  29. Quaglio GL, Lugoboni F, Pajusco B, Fornasiero A, Lechi A, Mezzelani P, Pattaro C, Don C. Des Jarlais, GICS. Heterosexual relationships among heroin users in Italy.
    Drug Alcohol Depend. 2004;75:207-13.

  30. Lugoboni F, Quaglio GL, Pajusco B, Foroni M, Blengio GS, Talamini G, Mezzelani P and Don C. Des Jarlais. Prevalence of hepatitis A among drug users in North-eastern Italy. Do they need to be vaccinated?

  31. Quaglio GL, Lugoboni F, Mezzelani P. HBV vaccination should be performed in service centres for drug users: an Italian experience. J Public Health (Oxf). 2004;26:320.

  32. Lugoboni F, Quaglio GL, Mezzelani P, Pajusco B, Casari R, Lechi A. Improving compliance in internal medicine: the motivational discussion. Ann Ital Med Int. 2004; 19:155-62.

  33. Lugoboni F, Quaglio G, Pajusco B, Civitelli P, Romano L, Bossi C, Spilimbergo I, Mezzelani P. Immunogenicity, reactogenicity and adherence to a combined hepatitis A and B vaccine in illicit drug users. Addiction. 2004 ;99:1560-4.

  34. Quaglio G, Lugoboni F, Pajusco B, Fornasiero A, Mezzelani P, Lechi A. Clinical manifestations of cocaine abuse. Ann Ital Med Int. 2004;19:291-301.

  35. Lugoboni F, Quaglio G, Pajusco B, Foroni M, Blengio G, Talamini G, Mezzelani P, Des Jarlais DC. Prevalence of hepatitis A among drug users in north-eastern Italy. Is vaccination necessary in low prevalence areas? Eur J Public Health 2005;15:464-6.

  36. Quaglio G, Lugoboni F, Fornasiero A, Lechi A, Gerra G, Mezzelani P. Dependence on zolpidem: two case reports of detoxification with flumazenil infusion. Int Clin Psychopharmacol. 2005;20:285-7.

  37. Quaglio G, Lugoboni F, Mezzelani P, Des Jarlais DC, Lechi A. Hepatitis vaccination among drug users.Vaccine. 2006 Jan 6; Epub ahead of print.

English